Blockade of interleukin 1 receptor in Still's disease affects activation of peripheral T-lymphocytes

J Rheumatol. 2008 Dec;35(12):2453-6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antirheumatic Agents / therapeutic use*
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Prednisone / therapeutic use
  • Still's Disease, Adult-Onset / drug therapy*
  • Still's Disease, Adult-Onset / immunology
  • T-Lymphocyte Subsets / immunology*

Substances

  • Antirheumatic Agents
  • Interleukin 1 Receptor Antagonist Protein
  • Cyclosporine
  • Prednisone